: Control of oral biofilm formation by an antimicrobial decapeptide. J Dent Res 2005, 84:1172–1177.PubMedCrossRef 35. Baker PJ, Coburn RA, Genco RJ, Evans RT: The in vitro inhibition

of microbial growth and plaque formation by surfactant drugs. J Periodontal Res 1978, 13:474–485.PubMedCrossRef 36. Semlali A, Leung KP, Curt S, Rouabhia M: Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, Momelotinib molecular weight human β-defensin, and cytokine expression by engineered human oral mucosa. Peptides 2011,32(5):859–867.PubMedCrossRef 37. Okkers DJ, Dicks LM, Silvester M, Joubert JJ, Odendaal HJ: Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus NVP-BGJ398 ic50 with a fungistatic effect on Candida albicans. J Appl Microbiol 1999, 87:726–734.PubMedCrossRef 38. Dixon DR, Jeffrey NR, Dubey VS, Leung KP: Antimicrobial peptide inhibition of Porphyromonas gingivalis 381-induced

hemagglutination is improved with a synthetic decapeptide. Peptides 2009, 30:2161–2167.PubMedCrossRef 39. Raines SM, Rane HS, Bernardo SM, Binder JL, Lee SA, et al.: Deletion of Vacuolar Proton-translocating ATPase Voa Isoforms Clarifies the Role of Vacuolar pH as a Determinant of Virulence-associated Traits in Candida albicans. J Biol Chem 2013, 288:6190–6201.PubMedCrossRef 40. Ariyachet C, Solis NV, Liu Y, Prasadarao NV, Filler SG, et al.: SR-Like RNA-Binding Protein Slr1 Affects Candida albicans Filamentation and Virulence. Infect Immun 2013, 81:1267–1276.PubMedCrossRef 41. Décanis N, Thymidylate synthase Savignac K, Rouabhia M: Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human beta-defensin 2 production. Cytokine 2009, 45:132–140.PubMedCrossRef 42. Zhang J, Silao FG, Bigol UG, Bungay AA, Nicolas MG, et al.: Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. PLoS One 2012, 7:e44192.PubMedCrossRef 43. Koshlukova SE, Araujo

MWB, Baev D, Edgerton M: Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans . Infect Immun 2000, 68:6848–6856.PubMedCrossRef 44. Vylkova S, Jang WS, Li W, Nayyar N, Edgerton M: Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase check details pathway. Eukaryot Cell 2007, 6:1876–1888.PubMedCrossRef 45. Jang WS, Bajwa JS, Sun JN, Edgerton M: Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans . Mol Microbiol 2010, 77:354–370.PubMedCrossRef 46. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL: Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001, 18:163–170.PubMed 47. Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, et al.